Lifecore Biomedical, Inc.

LFCR Healthcare Drug Manufacturers Specialty & Generic

In the quarter to June 2026, revenue fell 6.25%, EPS fell 216.7%, free cash flow fell 117.0% and total debt rose 15.3%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

6.38 0.06 −0.93%
Market cap
$244.1M
P/E
0.0×
Fwd P/E
−5.4×
Dividend yield
—
F-score
3/9
Altman Z
0.12
Beneish M
−3.15
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

May '25 May '24 May '23 May '22 May '21 May '20 May '19 May '18 May '17 May '16
Total current assets
85.68 81.03 93.88 116.67 148.32 157.11 133.04 97.06 81.28 86.30
Total non-current assets
153.67 172.93 159.67 158.04 354.60 384.21 386.05 307.64 277.33 256.35
Total Assets
239.34 253.96 253.55 274.70 502.92 541.31 519.09 404.70 358.61 342.65
Total current liabilities
30.18 38.87 39.29 176.58 101.89 164.39 137.09 88.38 51.45 56.34
Total non-current liabilities
161.73 161.19 179.17 10.30 198.25 145.88 111.86 63.77 79.00 73.96
Total liabilities
191.91 200.06 218.46 186.88 300.14 310.27 248.95 152.14 130.46 130.30
Common Equity (Total)
1.34 11.32 (4.23) 87.82 202.78 231.04 270.14 252.56 228.15 212.35
Shareholders Equity (Total)
47.43 53.90 35.09 87.82 202.78 231.04 270.14 252.56 228.15 212.35
Total Debt
151.99 149.90 166.55 148.16 193.90 190.32 148.98 72.94 53.97 61.15

Show all line items

In millions of $ except per-share values · columns are period end dates